{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:31:16Z","timestamp":1787682676427,"version":"build-2784847793"},"reference-count":18,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\nBackground:<\/jats:title>\nEpithelioid glioblastoma is a rare aggressive variant of glioblastoma multiforme (GBM), which was formally recognized by the World Health Organization classification of the central nervous system in 2016. Clinically, epithelioid GBMs are characterized by aggressive features, such as metastases and cerebrospinal fluid dissemination, and an extremely poor prognosis. A rare case of epithelioid GBM that was discovered as a multicentric glioma with different histopathology is reported.<\/jats:p>\n<\/jats:sec>\n\nCase Description:<\/jats:title>\nA 78-year-old man was admitted to our hospital with mild motor weakness of the right leg. Neuroimaging showed small masses in the left frontal and parietal lobes on magnetic resonance imaging. The abnormal lesion had been increasing rapidly for 3 weeks, and a new lesion appeared in the frontal lobe. 11C-methionine positron emission tomography (PET) showed abnormal uptake corresponding to the lesion. To reach a definitive diagnosis, surgical excision of the right frontal mass lesion was performed. Histological findings showed diffuse astrocytoma. Only radiotherapy was planned, but the left frontal and parietal tumors progressed further within a short period. Therefore, it was thought that these tumors were GBM, and a biopsy of the left parietal tumor was performed. The histological diagnosis was epithelioid GBM. Immunohistochemistry showed that most tumor cells were negatively stained for p53 and isocitrate dehydrogenase 1. BRAF<\/jats:italic> V600E mutations were not identified, but TERT<\/jats:italic> promoter mutations were identified. Immediately after surgery, the patient was given chemotherapy using temozolomide, extended local radiotherapy and then bevacizumab. After 6 months, he showed no signs of recurrence.<\/jats:p>\n<\/jats:sec>\n\nConclusion:<\/jats:title>\nEpithelioid GBM is one of the rarest morphologic subtypes of GBM and has a strongly infiltrative and aggressive nature. Therefore, careful identification of preoperative imaging studies and detailed evaluation of genetic studies are necessary to select the appropriate treatment for epithelioid GBM.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_544_2019","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T06:07:40Z","timestamp":1579241260000},"page":"8","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature"],"prefix":"10.25259","volume":"11","author":[{"given":"Daisuke","family":"Kohno","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Aki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirabe","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suehiro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shigekawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Kunieda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ehime University School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"10.25259\/SNI_544_2019\/ref-1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/jns.1963.20.2.0122","article-title":"The problem of multicentric gliomas","volume":"20","author":"Batzdorf","year":"1963","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_544_2019\/ref-2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12093","article-title":"Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma","volume":"40","author":"Broniscer","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.25259\/SNI_544_2019\/ref-3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_544_2019\/ref-4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12885-019-5678-1","article-title":"Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma","volume":"19","author":"Cuncannon","year":"2019","journal-title":"BMC Cancer"},{"key":"10.25259\/SNI_544_2019\/ref-5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_544_2019\/ref-6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1440-1789.2010.01166.x","article-title":"Rhabdoid glioblastoma: Case report and literature review","volume":"31","author":"He","year":"2011","journal-title":"Neuropathology"},{"key":"10.25259\/SNI_544_2019\/ref-7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12957-016-0907-4","article-title":"A case of multicentric gliomas in both supra and infratentorial regions with different histology: A case report","volume":"14","author":"Inoue","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.25259\/SNI_544_2019\/ref-8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40478-019-0774-7","article-title":"Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: Establishment and xenograft of a cell line to predict clinical efficacy","volume":"7","author":"Kanemaru","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.25259\/SNI_544_2019\/ref-9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0b013e31827f9c5e","article-title":"Epithelioid GBMs show a high percentage of BRAF V600E mutation","volume":"37","author":"Kleinschmidt-DeMasters","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/SNI_544_2019\/ref-10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0b013e3181ce107b","article-title":"Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6","volume":"34","author":"Kleinschmidt-DeMasters","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/SNI_544_2019\/ref-11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bpa.12566","article-title":"Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis","volume":"28","author":"Korshunov","year":"2018","journal-title":"Brain Pathol"},{"key":"10.25259\/SNI_544_2019\/ref-12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/neup.12258","article-title":"A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma","volume":"36","author":"Kuroda","year":"2016","journal-title":"Neuropathology"},{"key":"10.25259\/SNI_544_2019\/ref-13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.25259\/SNI_544_2019\/ref-14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/02688699109002887","article-title":"Multicentric malignant glioma","volume":"5","author":"Malcolm","year":"1991","journal-title":"Br J Neurosurg"},{"key":"10.25259\/SNI_544_2019\/ref-15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/02688699008993805","article-title":"Multicentric gliomas: Two case reports and a review of the literature","volume":"4","author":"Mishra","year":"1990","journal-title":"Br J Neurosurg"},{"key":"10.25259\/SNI_544_2019\/ref-16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10014-010-0010-4","article-title":"Rhabdoid glioblastoma in a child: Case report and literature review","volume":"28","author":"Momota","year":"2011","journal-title":"Brain Tumor Pathol"},{"key":"10.25259\/SNI_544_2019\/ref-17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bpa.12572","article-title":"BRAF V600E, TERT promoter mutations and CDKN2A\/B homozygous deletions are frequent in epithelioid glioblastomas: A histological and molecular analysis focusing on intratumoral heterogeneity","volume":"28","author":"Nakajima","year":"2018","journal-title":"Brain Pathol"},{"key":"10.25259\/SNI_544_2019\/ref-18","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.18632\/oncotarget.26932","article-title":"Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: A report of two cases","volume":"10","author":"Woo","year":"2019","journal-title":"Oncotarget"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/epithelioid-glioblastoma-presenting-as-multicentric-glioma-a-case-report-and-review-of-the-literature\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/epithelioid-glioblastoma-presenting-as-multicentric-glioma-a-case-report-and-review-of-the-literature\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T06:07:44Z","timestamp":1579241264000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/epithelioid-glioblastoma-presenting-as-multicentric-glioma-a-case-report-and-review-of-the-literature\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":18,"alternative-id":["10.25259\/SNI_544_2019"],"URL":"https:\/\/doi.org\/10.25259\/sni_544_2019","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"article-number":"8"}}